title: Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors.
authors.affiliation: Oral Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.|UFR Odontologie, 3 Chemin des Maraîchers, 31062, Toulouse CEDEX 9, France.
authors.forename: E
authors.initials: E
authors.lastname: Vigarios
authors.affiliation: Pathology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
authors.forename: L
authors.initials: L
authors.lastname: Lamant
authors.affiliation: Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Delord
authors.affiliation: Oral Medicine Department, Pôle Odontologie et Santé Buccale, Hôpital Pellegrin, Place Amélie-Raba-Léon, 33076, Bordeaux CEDEX, France.|UFR Odontologie Bordeaux, 16-20 Cours de la Marne, 33076, Bordeaux CEDEX, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Fricain
authors.affiliation: Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
authors.forename: C
authors.initials: C
authors.lastname: Chevreau
authors.affiliation: Pathology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
authors.forename: B
authors.initials: B
authors.lastname: Barrés
authors.affiliation: Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
authors.forename: C
authors.initials: C
authors.lastname: Gomez-Roca
authors.affiliation: Oral Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.|UFR Odontologie, 3 Chemin des Maraîchers, 31062, Toulouse CEDEX 9, France.
authors.forename: M
authors.initials: M
authors.lastname: Boulanger
authors.affiliation: Dermatology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
authors.forename: V
authors.initials: V
authors.lastname: Sibaud
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007211:Indoles / Q000009:adverse effects*; D007972:Leukoplakia, Oral / Q000139:chemically induced*; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D009061:Mouth Mucosa; D009062:Mouth Neoplasms / Q000139:chemically induced*; D009154:Mutation / Q000235:genetics; D010091:Oximes / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D012878:Skin Neoplasms / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D007211:Indoles; D010091:Oximes; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; C561627:dabrafenib